| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 May 2025 | 30 Apr 2025 |
| Arihant Capital Markets Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2025 inter alia to consider and approve 1. To consider and approve Audited Consolidated and Standalone Financial Results of the Company for the quarter and year ending on March 31 2025 along with Auditors Report thereon; 2. To consider and recommend dividend if any for the financial year ended on March 31 2025. 3. To consider and approve the alteration in object clause of Memorandum of Association of Company. 4. Other incidental and ancillary matters. Recommended a dividend of 50% i.e. ? 0.50/- per equity share on face value of ? 1/- each for the financial year ended March 31, 2025, subject to approval of the shareholders in the forthcoming Annual General Meeting of the Company. Consolidated and Standalone Financial Results for the quarter and year ended on March 31, 2025 (As Per BSE Announcement Dated on:10.05.2025) | ||
| Board Meeting | 10 Feb 2025 | 31 Jan 2025 |
| ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31 2024. 2. Other incidental and ancillary matters. Financial Results for the quarter and nine months ended on December 31, 2024 We wish to inform you that the Board of Directors of the Company in their meeting held today i.e. February 10, 2025, inter-alia, approved and taken on record the following businesses: 1. Unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended on 31st December 2024 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015 along with the Limited Review Report issued by statutory auditor of the Company. 2. Other businesses incidental and ancillary to the Companys business (As Per Bse Announcement Dated on 10.02.2025) | ||
| Board Meeting | 7 Nov 2024 | 28 Oct 2024 |
| Quarterly Results Inter alia, to consider and approve:- 1. To consider the appointment of Mr. Arpit Jain (DIN: 06544441), Joint Managing Director as the Chief Executive Officer of the Company. 1. Unaudited Standalone & Consolidated Financial Results for quarter and half year ended on September 30, 2024 along with the Limited Review Report thereon; 2. Appointment of Mr. Arpit Jain (DIN: 06544441) as Chief Executive Officer of the Company; 3. Approval for incorporation of a wholly owned subsidiary Read less.. Mr. Arpit Jain also appointed as Chief Executive Officer of the Company Financial Results for the quarter and half year ended on September 30, 2024 (As Per BSE Announcement dated on 07.11.2024) | ||
| Board Meeting | 6 Sep 2024 | 30 Aug 2024 |
| ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 inter alia to consider and approve 1. Fund Raising by way of equity shares or other instruments or securities through permissible modes including Right Issue / QIP or any other permissible mode and/ or combination thereof as may be considered appropriate subject to such statutory/ regulatory approvals as applicable. 2. Other incidental and ancillary matters. | ||
| Board Meeting | 20 Jul 2024 | 12 Jul 2024 |
| ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/07/2024 inter alia to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2024 along with Limited Review Report thereon; 2. Other incidental and ancillary matters. Outcome of Board Meeting Financial Results for the quarter ended on June 30, 2024 (As per BSE Announcement Dated on 20/07/2024) | ||
| Board Meeting | 21 Jun 2024 | 13 Jun 2024 |
| ARIHANT CAPITAL MARKETS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/06/2024 inter alia to consider and approve 1. Consider and approve the divestment of 100% Equity stake/investment held in its wholly owned subsidiary company viz. Arihant Insurance Broking Services Limited subject to the approval of IRDAI. 2. Other incidental and ancillary matters. Divestment of 100% Equity stake/investment held in its wholly owned subsidiary company: The Board considered and approved the divestment of 100% Equity stake/investment held in its wholly owned subsidiary company viz., Arihant Insurance Broking Services Limited subject to the approval of IRDAI. (As Per BSE Announcement dated on 21.06.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.